Oncology Center
Oswaldo Cruz German Hospital
Santo Andre, United States
Erivelto Volpi, MD, PhD. Head and Neck Surgery, Oswaldo Cruz German Hospital - Brazil
Dr. Erivelto is a surgeon specializing in thyroid and parathyroid diseases, with a focus on thyroid cancer and minimally invasive therapies. Following his training in Seoul, he became one of Brazil's pioneers of thermal treatments for thyroid nodules. Since 2018, he has successfully treated over 700 patients with benign and malignant thyroid nodules, parathyroid adenomas, and cervical metastases. Additionally, he provides training in thermal ablation and has imparted his knowledge to over 100 doctors from Brazil and other countries. Currently, he is an active member of several essential societies' committees and services, including the American Academy of Otolaryngology-Head and Neck Surgery, the American Head and Neck Society, the American Thyroid Association, the North American Society of Interventional Thyroidology, and the Latin American Thyroid Society. Additionally, he serves as an Associate Editor of the Frontiers in Endocrinology Journal and is a peer reviewer for numerous scientific publications.
Ultrasound Office-based for the Otolaryngologists
Saturday, October 17, 2026
1:00 PM - 2:00 PM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Dealing with the Parathyroid Function After Total Thyroidectomies, Tips and Tricks for Best Results
Sunday, October 18, 2026
9:30 AM - 10:30 AM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Sunday, October 18, 2026
2:30 PM - 3:30 PM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Thermal Ablation - A Game Changer in the Management of Benign and Malignant Thyroid nĂ³dules
Monday, October 19, 2026
9:30 AM - 10:30 AM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.